Sökning: (WFRF:(Bueno de Mesquita H. Bas)) pers:(Sanchez Maria Jose) > (2020-2022) > Development and val...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 09603naa a2200949 4500 | |
001 | oai:lup.lub.lu.se:c74fe4ee-ccb6-4073-98cd-6ec6e0579091 | |
003 | SwePub | |
008 | 210112s2021 | |||||||||||000 ||eng| | |
009 | oai:DiVA.org:umu-178982 | |
024 | 7 | a https://lup.lub.lu.se/record/c74fe4ee-ccb6-4073-98cd-6ec6e05790912 URI |
024 | 7 | a https://doi.org/10.1186/s12916-020-01826-02 DOI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-1789822 URI |
040 | a (SwePub)lud (SwePub)umu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a art2 swepub-publicationtype |
072 | 7 | a ref2 swepub-contenttype |
100 | 1 | a Aleksandrova, Krasimirau Leibniz Institute for Prevention Research and Epidemiology - BIPS GmbH,German Institute of Human Nutrition,University of Potsdam4 aut |
245 | 1 0 | a Development and validation of a lifestyle-based model for colorectal cancer risk prediction : the LiFeCRC score |
264 | c 2021-01-04 | |
264 | 1 | b Springer Science and Business Media LLC,c 2021 |
520 | a Background: Nutrition and lifestyle have been long established as risk factors for colorectal cancer (CRC). Modifiable lifestyle behaviours bear potential to minimize long-term CRC risk; however, translation of lifestyle information into individualized CRC risk assessment has not been implemented. Lifestyle-based risk models may aid the identification of high-risk individuals, guide referral to screening and motivate behaviour change. We therefore developed and validated a lifestyle-based CRC risk prediction algorithm in an asymptomatic European population. Methods: The model was based on data from 255,482 participants in the European Prospective Investigation into Cancer and Nutrition (EPIC) study aged 19 to 70 years who were free of cancer at study baseline (1992–2000) and were followed up to 31 September 2010. The model was validated in a sample comprising 74,403 participants selected among five EPIC centres. Over a median follow-up time of 15 years, there were 3645 and 981 colorectal cancer cases in the derivation and validation samples, respectively. Variable selection algorithms in Cox proportional hazard regression and random survival forest (RSF) were used to identify the best predictors among plausible predictor variables. Measures of discrimination and calibration were calculated in derivation and validation samples. To facilitate model communication, a nomogram and a web-based application were developed. Results: The final selection model included age, waist circumference, height, smoking, alcohol consumption, physical activity, vegetables, dairy products, processed meat, and sugar and confectionary. The risk score demonstrated good discrimination overall and in sex-specific models. Harrell’s C-index was 0.710 in the derivation cohort and 0.714 in the validation cohort. The model was well calibrated and showed strong agreement between predicted and observed risk. Random survival forest analysis suggested high model robustness. Beyond age, lifestyle data led to improved model performance overall (continuous net reclassification improvement = 0.307 (95% CI 0.264–0.352)), and especially for young individuals below 45 years (continuous net reclassification improvement = 0.364 (95% CI 0.084–0.575)). Conclusions: LiFeCRC score based on age and lifestyle data accurately identifies individuals at risk for incident colorectal cancer in European populations and could contribute to improved prevention through motivating lifestyle change at an individual level. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Hälsovetenskapx Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi0 (SwePub)303022 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Health Sciencesx Public Health, Global Health, Social Medicine and Epidemiology0 (SwePub)303022 hsv//eng |
653 | a Cancer prevention | |
653 | a Colorectal cancer | |
653 | a Lifestyle behaviour | |
653 | a Risk prediction | |
653 | a Risk screening | |
653 | a Colorectal cancer | |
700 | 1 | a Reichmann, Robinu University of Potsdam,German Institute of Human Nutrition4 aut |
700 | 1 | a Kaaks, Rudolfu German Cancer Research Centre4 aut |
700 | 1 | a Jenab, Mazdau International Agency for Research on Cancer, World Health Organization,Imperial College London4 aut |
700 | 1 | a Bueno-de-Mesquita, H. Basu National Institute for Public Health and the Environment (RIVM),Imperial College London4 aut |
700 | 1 | a Dahm, Christina C.u Aarhus University4 aut |
700 | 1 | a Eriksen, Anne Kirstineu Danish Cancer Society4 aut |
700 | 1 | a Tjønneland, Anneu Danish Cancer Society4 aut |
700 | 1 | a Artaud, Fannyu Institut Gustave Roussy,University of Paris-Saclay4 aut |
700 | 1 | a Boutron-Ruault, Marie Christineu Institut Gustave Roussy,University of Paris-Saclay4 aut |
700 | 1 | a Severi, Gianlucau Institut Gustave Roussy,University of Paris-Saclay,University of Florence4 aut |
700 | 1 | a Hüsing, Anikau German Cancer Research Centre4 aut |
700 | 1 | a Trichopoulou, Antoniau Hellenic Health Foundation, Athens4 aut |
700 | 1 | a Karakatsani, Annau National and Kapodistrian University of Athens,Hellenic Health Foundation, Athens4 aut |
700 | 1 | a Peppa, Eleniu Hellenic Health Foundation, Athens4 aut |
700 | 1 | a Panico, Salvatoreu University of Naples Federico II4 aut |
700 | 1 | a Masala, Giovannau Institute for Cancer Research, Prevention and Clinical Network (ISPRO)4 aut |
700 | 1 | a Grioni, Sarau Istituto Nazionale dei Tumori4 aut |
700 | 1 | a Sacerdote, Carlottau Citta' della Salute e della Scienza Hospital-University of Turin4 aut |
700 | 1 | a Tumino, Rosariou Provincial Health Authority (ASP) Ragusa4 aut |
700 | 1 | a Elias, Sjoerd G.u University Medical Center Utrecht,Utrecht University4 aut |
700 | 1 | a May, Anne M.u University Medical Center Utrecht,Utrecht University4 aut |
700 | 1 | a Borch, Kristin B.u UiT The Arctic University of Norway, Tromsø4 aut |
700 | 1 | a Sandanger, Torkjel M.u UiT The Arctic University of Norway, Tromsø4 aut |
700 | 1 | a Skeie, Guriu UiT The Arctic University of Norway, Tromsø4 aut |
700 | 1 | a Sánchez, Maria Joseu CIBER Epidemiology and Public Health (CIBERESP),Andalusian School Of Public Health (EASP),University of Granada4 aut |
700 | 1 | a Huerta, José Maríau CIBER Epidemiology and Public Health (CIBERESP),Murcia Regional Health Council4 aut |
700 | 1 | a Sala, Núriau Bellvitge Biomedical Research Institute,Catalan Institute of Oncology4 aut |
700 | 1 | a Gurrea, Aurelio Barricarteu Health Research Institute of Navarra (IDISNA),Navarre Public Health Institute (ISPN),CIBER Epidemiology and Public Health (CIBERESP)4 aut |
700 | 1 | a Quirós, José Ramónu Public Health Directorate4 aut |
700 | 1 | a Amiano, Pilaru Basque Regional Health Department,CIBER Epidemiology and Public Health (CIBERESP),Biodonostia Health Research Institute4 aut |
700 | 1 | a Berntsson, Jonnau Lund University,Lunds universitet,Personlig patologi och cancerbehandling,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Personalized Pathology & Cancer Therapy,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments4 aut0 (Swepub:lu)jo6056be |
700 | 1 | a Drake, Isabelu Lund University,Lunds universitet,Diabetes - kardiovaskulär sjukdom,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Diabetes - Cardiovascular Disease,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments4 aut0 (Swepub:lu)med-ihm |
700 | 1 | a van Guelpen, Bethanyu Umeå universitet,Umeå University,Onkologi,Wallenberg centrum för molekylär medicin vid Umeå universitet (WCMM)4 aut0 (Swepub:umu)beyvan99 |
700 | 1 | a Harlid, Sophiau Umeå universitet,Umeå University,Onkologi4 aut0 (Swepub:umu)soha0105 |
700 | 1 | a Key, Timu University of Oxford4 aut |
700 | 1 | a Weiderpass, Elisabeteu International Agency for Research on Cancer, World Health Organization4 aut |
700 | 1 | a Aglago, Elom K.u International Agency for Research on Cancer, World Health Organization4 aut |
700 | 1 | a Cross, Amanda J.u Imperial College London4 aut |
700 | 1 | a Tsilidis, Konstantinos K.u University of Ioannina,Imperial College London4 aut |
700 | 1 | a Riboli, Eliou Imperial College London4 aut |
700 | 1 | a Gunter, Marc J.u International Agency for Research on Cancer, World Health Organization4 aut |
710 | 2 | a Leibniz Institute for Prevention Research and Epidemiology - BIPS GmbHb German Institute of Human Nutrition4 org |
773 | 0 | t BMC Medicined : Springer Science and Business Media LLCg 19:1q 19:1x 1741-7015 |
856 | 4 | u http://dx.doi.org/10.1186/s12916-020-01826-0x freey FULLTEXT |
856 | 4 | u https://bmcmedicine.biomedcentral.com/track/pdf/10.1186/s12916-020-01826-0 |
856 | 4 | u https://doi.org/10.1186/s12916-020-01826-0y Fulltext |
856 | 4 | u https://umu.diva-portal.org/smash/get/diva2:1526024/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 8 | u https://lup.lub.lu.se/record/c74fe4ee-ccb6-4073-98cd-6ec6e0579091 |
856 | 4 8 | u https://doi.org/10.1186/s12916-020-01826-0 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-178982 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy